南美超级胎牛血清999尝鲜特惠
转染试剂低至5折
基质胶阶梯特惠
积分商城,好礼送不停
南美超级胎牛血清999尝鲜特惠
转染试剂低至5折
基质胶阶梯特惠
积分商城,好礼送不停

肝脏亲环蛋白D缺失通过改善脂肪变性和炎症抑制早期NASH进展

Liver cyclophilin D deficiency inhibits the progression of early NASH by ameliorating steatosis and inflammation

Xiaoling Li, Mengjiao Yang, Hang Sun, Md Reyad ul Ferdous, Ling Gao, Jiajun Zhao, Yongfeng Song

Journal:BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS

IF:3.32

DOI:10.1016/j.bbrc.2022.01.059

PMID:35085894

Published:2022-01-18

research field:分子生物学免疫学生物技术病毒学

Abstract

Cyclophilin D (CypD) can stimulate the opening of the membrane permeability transition pore (mPTP) and regulate mitochondrial function. Whole-body knockout of CypD improved high fat diet-induced hepatic steatosis by reducing the excess opening of the mPTP and lipid deposition . However, whether CypD significantly ameliorates nonalcoholic steatohepatitis (NASH) has not been studied. Therefore, we established liver-specific CypD knockout (CypD LKO) mice and fed a HFHC diet to induce NASH. Compared with the wild-type mice, the CypD LKO not only showed improved lipid deposition and insulin resistance by increasing fatty acid oxidation but also displayed ameliorated hepatic inflammation, although the symptoms of fibrosis in the NASH model were not significantly improved. In addition, we used bile duct ligation (BDL) or a 0.1% 3,5-diethoxycarbonyl-1,4-dihydrocollidine (DDC) diet to induce cholestatic disease and found that CypD LKO had also no significant effect on acute fibrosis. Thus, CypD LKO can inhibit the progression of early NASH by ameliorating steatosis and inflammatory symptoms. These results suggest a new strategy for the treatment of early NASH.

本文使用的Yeasen产品

购物车
客服
转染试用